Cargando…
Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome
Aerosol inhalation delivery of ceftriaxone in mice was investigated. An ultrasonic nebulizer within the ranges of mean particle diameter 0.5–1.5 μm and mass concentration 0.01–0.6 μg/cm(3) was used in inhalation experiments. Pharmacokinetic measurements were carried out using a nose-only chamber. Ce...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598611/ https://www.ncbi.nlm.nih.gov/pubmed/36289963 http://dx.doi.org/10.3390/antibiotics11101305 |
_version_ | 1784816377745375232 |
---|---|
author | Valiulin, Sergey V. Onischuk, Andrei A. Baklanov, Anatoly M. An’kov, Sergey V. Dubtsov, Sergey N. Alekseev, Alexander A. Shkil, Nikolay N. Nefedova, Ekaterina V. Plokhotnichenko, Maria E. Tolstikova, Tatyana G. Dolgov, Arseniy M. Dultseva, Galina G. |
author_facet | Valiulin, Sergey V. Onischuk, Andrei A. Baklanov, Anatoly M. An’kov, Sergey V. Dubtsov, Sergey N. Alekseev, Alexander A. Shkil, Nikolay N. Nefedova, Ekaterina V. Plokhotnichenko, Maria E. Tolstikova, Tatyana G. Dolgov, Arseniy M. Dultseva, Galina G. |
author_sort | Valiulin, Sergey V. |
collection | PubMed |
description | Aerosol inhalation delivery of ceftriaxone in mice was investigated. An ultrasonic nebulizer within the ranges of mean particle diameter 0.5–1.5 μm and mass concentration 0.01–0.6 μg/cm(3) was used in inhalation experiments. Pharmacokinetic measurements were carried out using a nose-only chamber. Ceftriaxone concentration in blood serum and its mass in the lungs of mice were measured as a function of time using high-performance liquid chromatography. The body-delivered dose was within the range 3–5 mg/kg. The antibacterial effect of aerosolized ceftriaxone was investigated for mice infected with Klebsiella pneumoniae 82 and Staphylococcus aureus ATCC 25 953. The survival rate for infected mice after the treatment with ceftriaxone aerosol revealed the high antibacterial efficiency of this kind of treatment. |
format | Online Article Text |
id | pubmed-9598611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95986112022-10-27 Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome Valiulin, Sergey V. Onischuk, Andrei A. Baklanov, Anatoly M. An’kov, Sergey V. Dubtsov, Sergey N. Alekseev, Alexander A. Shkil, Nikolay N. Nefedova, Ekaterina V. Plokhotnichenko, Maria E. Tolstikova, Tatyana G. Dolgov, Arseniy M. Dultseva, Galina G. Antibiotics (Basel) Article Aerosol inhalation delivery of ceftriaxone in mice was investigated. An ultrasonic nebulizer within the ranges of mean particle diameter 0.5–1.5 μm and mass concentration 0.01–0.6 μg/cm(3) was used in inhalation experiments. Pharmacokinetic measurements were carried out using a nose-only chamber. Ceftriaxone concentration in blood serum and its mass in the lungs of mice were measured as a function of time using high-performance liquid chromatography. The body-delivered dose was within the range 3–5 mg/kg. The antibacterial effect of aerosolized ceftriaxone was investigated for mice infected with Klebsiella pneumoniae 82 and Staphylococcus aureus ATCC 25 953. The survival rate for infected mice after the treatment with ceftriaxone aerosol revealed the high antibacterial efficiency of this kind of treatment. MDPI 2022-09-25 /pmc/articles/PMC9598611/ /pubmed/36289963 http://dx.doi.org/10.3390/antibiotics11101305 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Valiulin, Sergey V. Onischuk, Andrei A. Baklanov, Anatoly M. An’kov, Sergey V. Dubtsov, Sergey N. Alekseev, Alexander A. Shkil, Nikolay N. Nefedova, Ekaterina V. Plokhotnichenko, Maria E. Tolstikova, Tatyana G. Dolgov, Arseniy M. Dultseva, Galina G. Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome |
title | Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome |
title_full | Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome |
title_fullStr | Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome |
title_full_unstemmed | Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome |
title_short | Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome |
title_sort | aerosol inhalation delivery of ceftriaxone in mice: generation procedure, pharmacokinetics, and therapeutic outcome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598611/ https://www.ncbi.nlm.nih.gov/pubmed/36289963 http://dx.doi.org/10.3390/antibiotics11101305 |
work_keys_str_mv | AT valiulinsergeyv aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT onischukandreia aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT baklanovanatolym aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT ankovsergeyv aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT dubtsovsergeyn aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT alekseevalexandera aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT shkilnikolayn aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT nefedovaekaterinav aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT plokhotnichenkomariae aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT tolstikovatatyanag aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT dolgovarseniym aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome AT dultsevagalinag aerosolinhalationdeliveryofceftriaxoneinmicegenerationprocedurepharmacokineticsandtherapeuticoutcome |